510(k) K201525
K201525 is an FDA 510(k) premarket notification submitted by Apple, Inc. for the device "ECG App". The FDA issued a decision of Substantially Equivalent on Oct 8, 2020. The device falls under product code QDA (Electrocardiograph Software For Over-The-Counter Use), a Class II device regulated under 21 CFR 870.2345. Apple, Inc. has 11 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 8, 2020
- Date Received
- Jun 8, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Electrocardiograph Software For Over-The-Counter Use
- Device Class
- Class II
- Regulation Number
- 870.2345
- Review Panel
- CV
- Submission Type
- 510(k)
An electrocardiograph software device for over-the-counter use creates, analyzes, and displays electrocardiograph data, and can provide information for identifying cardiac arrhythmias. This device is not intended to provide a diagnosis.
Need the full FDA record for Apple, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.